读者在线:用户名 密码
首页期刊简介投稿须知期刊目录专家风采编委会特约编委特邀顾问广告发行联系我们

通知:

根据中华医学电子音像出版社通知,从即日起,本网站不再提供杂志发表稿件全文。如有需要,请登录中华医学会资源库,注册账号下载。

附:中华医学会资源库网址:https://zhxhbyyxzz.cma-cmc.com.cn/CN/2095-2015/home.shtml

本刊编辑部

2022年6月1日




刊物信息more
期刊名称:中华消化病与影像杂志
              (电子版)
主管单位:中华人民共和国国家
           卫生健康委员会
主办单位:中华医学会
承办单位:山东省第二人民医院(山东省耳鼻喉医院)
总 编 辑: 王宝成   孙钢
 
网 址http://www.zhxhbyyxzz.com
地 址
济南市槐荫区段兴西路4号
        
  中华消化病与影像杂志( 电子版)
编辑部
电 话:0531-83086377
    15564155687编辑部微信号

邮政编码:250022

电子邮箱:zhxhbyyxzz@126.com
国际标准刊号:ISSN 2095-2015
国内统一刊号:CN 11-9312/R
访问统计
您是第 3913113位浏览者
  您当前的位置:首页 >> 正文

双氯芬酸钠预防经十二指肠镜逆行胰胆管造影取石术后胰腺炎和高淀粉酶血症的疗效 [中文引用][英文引用]

Efficacy of diclofenac sodium in preventing pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography stone extraction 

作者:刘苗苗1   夏阳2              
作者(英文): 
单位(英文): 
分类号:
出版年·卷·期(页码):2022·12·第3期(146-149)
DOI: 10.3877/cma.j.issn.2095-2015.2022.03.005
-----摘要:-------------------------------------------------------------------------------------------

 [摘要]目的探究双氯芬酸钠预防经十二指肠镜逆行胰胆管造影(ERCP)取石术后胰腺炎和高淀粉酶血症的疗效,以及是否可通过影响前列腺素E2(PEG2)的表达来降低ERCP术后胰腺炎的发生率。方法按完全随机法将2019年6月至2019年12月皖南医学院第一附属医院拟行ERCP取石术的94例患者分为双氯芬酸钠组(48例,术前15min给予100mg双氯芬酸钠栓纳肛)、对照组(46例,术前15min给予100mg甘油灌肠剂纳肛)。观察两组患者术前、术后3h、术后24h血清淀粉酶、脂肪酶水平,采用ELISA法检测两组患者血清PEG2表达水平,比较两组患者胰腺炎、高淀粉酶血症的发生率以及血清PEG2表达水平差异。结果双氯芬酸钠组术后胰腺炎发生率明显降低,较对照组差异有统计学意义(P<0.05),但术后两组患者间高淀粉酶血症发生率差异无统计学意义(P>0.05)。术前两组患者间PEG2滴度差异无统计学意义(P>0.05)。术后3h双氯芬酸组血清PEG2滴度低于对照组,差异有统计学意义(P<0.05)。术后24h两组患者血清PEG2滴度差异无统计学意义,且恢复到术前水平(P>0.05)。结论双氯芬酸钠可预防ERCP取石术后胰腺炎的发生,可能与其降低血清PEG2的表达水平有关。

-----英文摘要:---------------------------------------------------------------------------------------

 [Abstract]  Objective  To investigate the efficacy of diclofenac sodium in preventing pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography (ERCP) stone extraction, and whether it can reduce the incidence of post-ERCP pancreatitis by affecting the expression of serum prostaglandin E2 (PEG2). Methods  According to random method, 94 patients who underwent ERCP stone extraction were divided into diclofenac sodium group (48 patients were given 100 mg diclofenac sodium for anal insertion 15 minutes before operation) and control group (46 patients were given 100 mg glycerol enema for anal insertion 15 minutes before operation). Serum amylase and lipase levels of the two groups were observed before and 3 hours and 24 hours after ERCP. ELISA was used to detected the levels of serum PEG2 in the two groups. The incidences of pancreatitis and hyperamylasemia and the expression levels of serum PEG2 were compared between the two groups. Results  The incidence of post-ERCP pancreatitis in the diclofenac sodium group was significantly lower than that in the control group, with a statistically significant difference (P<0.05), but there was no statistically significant difference in the incidence of post-ERCP hyperamylasemia between the two groups (P>0.05). There was no statistically significant difference in PEG2 titer between the two groups before ERCP (P>0.05). The serum PEG2 titer in the diclofenac sodium group was lower than that in the control group 3 hours after ERCP, with a statistically significant difference (P<0.05). There was no statistically significant difference in serum PEG2 titer between the two groups 24 hours after ERCP, and returned to the preoperative level (P>0.05). Conclusion  Diclofenac sodium can effectively prevent pancreatitis after ERCP stone extraction, which may be related to the decrease of serum PGE2 expression level.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《中华消化病与影像杂志(电子版)》!您是该文第 1866 位读者!

若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式: 刘苗苗1 ,,夏阳2 ,, ,, ,, , ,.双氯芬酸钠预防经十二指肠镜逆行胰胆管造影取石术后胰腺炎和高淀粉酶血症的疗效.中华消化病与影像杂志(电子版).2022;12(3):146-149.
英文著录格式: .Efficacy of diclofenac sodium in preventing pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography stone extraction .No Title Settings.2022;12(3):146-149.

与该文相关的文章(仅限于本刊内

已投本刊未发表相似文章

地址:山东济南市槐荫区段兴西路4号,山东省第二人民医院《中华消化病与影像杂志(电子版)》编辑部;

邮政编码:250022;电话:0531-83086377;投稿邮箱:zhxhbyyxzz@126.com  鲁公网安备 37010402001170号

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:010-60213898

鲁ICP备18044012号-6